Roffman Miller Associates Inc Merck & Co., Inc. Transaction History
Roffman Miller Associates Inc
- $1.64 Billion
- Q3 2024
A detailed history of Roffman Miller Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Roffman Miller Associates Inc holds 228,733 shares of MRK stock, worth $22.4 Million. This represents 1.59% of its overall portfolio holdings.
Number of Shares
228,733
Previous 253,672
9.83%
Holding current value
$22.4 Million
Previous $31.4 Million
17.29%
% of portfolio
1.59%
Previous 2.07%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.5 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.43 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.8 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $248B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...